# Single Dose of Clonazepam Versus Intermiittent Diazepam for Febrile Seizures Prevention

> **NCT04364321** · NA · UNKNOWN · sponsor: **Queen Sirikit National Institute of Child Health** · enrollment: 74 (estimated)

## Conditions studied

- Recurrent Febrile Convulsion

## Interventions

- **DRUG:** Clonazepam 0.5 MG
- **DRUG:** Diazepam Tablets

## Key facts

- **NCT ID:** NCT04364321
- **Lead sponsor:** Queen Sirikit National Institute of Child Health
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-13
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2021-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04364321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04364321, "Single Dose of Clonazepam Versus Intermiittent Diazepam for Febrile Seizures Prevention". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04364321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*